Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

NCT02382068 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients were enrolled to trial

Conditions

Malignant Neoplasm
Ototoxicity

Interventions

DRUG: Dexamethasone
OTHER: Placebo
DRUG: Cisplatin

Sponsor

Aaron Moberly